Literature DB >> 30854508

Papillary thyroid carcinoma with bilateral axillary lymph node involvement: a case report outlining hypothesis for locoregional spread and therapeutic implications.

Raul Caso1, Anthony M Villano1, Whitney Sutton1, Randi Alexander1, Diana L Caragacianu2.   

Abstract

Axillary lymph node involvement (ALNI) in well differentiated papillary thyroid carcinoma (WDPTC) is a rare sequela of disease presentation. We report a case of PTC with extensive cervical lymph node involvement, local extension to the skin of the neck and bilateral ALNI without evidence of distant disease. We posit that ALNI represents local extension of disease rather than distant metastasis. Therefore, in the absence of distant spread, ALNI should result in surgical intervention. This optimizes removal of all bulky disease and increases effectiveness of radioactive iodine (RAI) therapy. Future research centered on genomics should focus on ascertaining the behavior and prognosis of such cases, especially when anatomic spread is discordant with biologic behavior.

Entities:  

Keywords:  Papillary thyroid carcinoma (PTC); axillary lymph node involvement (ALNI); local extension; thyroid cancer

Year:  2019        PMID: 30854508      PMCID: PMC6378239          DOI: 10.21037/acr.2019.01.02

Source DB:  PubMed          Journal:  AME Case Rep        ISSN: 2523-1995


  23 in total

Review 1.  The role of lymphoscintigraphy in the detection of lymph node drainage in melanoma.

Authors:  Roger F Uren; John F Thompson; Robert Howman-Giles; David K V Chung
Journal:  Surg Oncol Clin N Am       Date:  2006-04       Impact factor: 3.495

2.  Axillary nodal metastasis from oral and maxillofacial cancers: a report of 3 cases.

Authors:  Aung Lwin Oo; Satoshi Yamaguchi; Hiroshi Iwaki; Teruo Amagasa
Journal:  J Oral Maxillofac Surg       Date:  2004-08       Impact factor: 1.895

3.  Sentinel lymph node surgery in locally recurrent breast cancer.

Authors:  Judy C Boughey; Merrick I Ross; Gildy V Babiera; Isabelle Bedrosian; Barry W Feig; Rosa F Hwang; Henry M Kuerer; Kelly K Hunt
Journal:  Clin Breast Cancer       Date:  2006-08       Impact factor: 3.225

Review 4.  Noncervical lymph node metastasis from head and neck cancer.

Authors:  L P Kowalski
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2001 Jul-Aug       Impact factor: 1.538

5.  Axillary lymph node metastasis in recurrence of papillary thyroid carcinoma: a case report.

Authors:  Vincent Ers; Christine Galant; Jacques Malaise; Jacques Rahier; Chantal Daumerie
Journal:  Wien Klin Wochenschr       Date:  2006-03       Impact factor: 1.704

6.  Distribution of lymph node micrometastasis in pN0 well-differentiated thyroid carcinoma.

Authors:  Sameer William Qubain; Shizuo Nakano; Masamichi Baba; Sonshin Takao; Takashi Aikou
Journal:  Surgery       Date:  2002-03       Impact factor: 3.982

7.  Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.

Authors:  Sin-Ming Chow; Stephen C K Law; John K C Chan; Siu-Kie Au; Stephen Yau; Wai-Hon Lau
Journal:  Cancer       Date:  2003-07-01       Impact factor: 6.860

8.  Axillary lymph node recurrence of papillary thyroid microcarcinoma: report of a case.

Authors:  Kenta Koike; Teruhiko Fujii; Hiroshi Yanaga; Shino Nakagawa; Goro Yokoyama; Toshiro Yahara; Mai Hanzawa; Seiya Kato; Kazuo Shirouzu
Journal:  Surg Today       Date:  2004       Impact factor: 2.549

9.  Contralateral axillary sentinel lymph node drainage in breast cancer: a case report.

Authors:  Emmanuel Barranger; Françoise Montravers; Khaldoun Kerrou; Olivier Marpeau; Irena Raileanu; Martine Antoine; Jean Noel Talbot; Serge Uzan
Journal:  J Surg Oncol       Date:  2004-06-01       Impact factor: 3.454

10.  Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients.

Authors:  P J Tanis; O E Nieweg; R A Valdés Olmos; J L Peterse; E J Th Rutgers; C A Hoefnagel; B B R Kroon
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.